why is the semaglutide not working for me 12 Reasons You're Losing Weight on Semaglutide and Dizziness: Causes, Connections

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

In practice, providers often report multi-day delays for GLP-1 scripts

Novo Nordisks semaglutide, the GLP-1 analog used in Ozempic and Wegovy, showed an average weight loss of 10.6% at 68 weeks with the 2.4 mg dose in adults with type 2 diabetes and obesity or overweight in the STEP 2 Phase 3 trial

Used in conjunction with diet and exercise, Semaglutide helps patients stick to a reduced-calorie diet, enhancing the weight loss process

This insight helps PlexusDx providers predict your metabolic responses and coordinate semaglutide dosing with thyroid monitoring for more stable, personalized care

Clinical trials and randomized controlled studies have shown that semaglutide can potentially improve glycemic control, reduce body weight , and decrease cardiovascular disease